NCT00478452View on ClinicalTrials.gov

Dendritic Cell Vaccine for High Risk Ovarian Cancer Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
Interventions
BIOLOGICAL

DC-Ova

BIOLOGICAL

DC Ova with Cyclophosphamide

Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

Fox Chase Cancer Center

OTHER

lead

University of Pennsylvania

OTHER

NCT00478452 - Dendritic Cell Vaccine for High Risk Ovarian Cancer Patients | Biotech Hunter | Biotech Hunter